Replies to post #1170 on Israel-Medical-Healthcare

[ghmm]

Thanks again for the info! I'll have to look more at the Eye indications. Does the lack of a complete dose response cause you to be more cautious especially with your other point about placebo crossovers? I didn't see them listed in the JP Morgan agenda

http://jpmorgan.metameetings.com/webcasts/healthcare13/agenda.html